Published in Gene Therapy Weekly, February 10th, 2005
In the study, Perlegen will individually genotype single nucleotide polymorphisms, or SNPs, in hundreds of patients, analyze the results to determine the genetic variations associated with differential therapeutic response, and determine the populations that might respond best to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.